Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Sight-Threatening Condition in Severe Thyroid Eye Disease: How We Should Manage

ACTA MEDICA INDONESIANA · Vol. 54 No. 1 (2022)

ISSN
2338-2732, 0125-9326
Terbit
2022-04-08
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Thyroid eye disease (TED) is an autoimmune disorder that is associated with thyroid gland dysfunction which causes muscle and orbital fat enlargement. This case report is aimed to present a case of sight-threatening TED and how we should manage this condition. We present a case of patient with chief complaint of vision loss and prominent eyes for 5 months prior to the visit to our eye hospital. Patient had sought advice from an ophthalmologist and internist. TED was eventually diagnosed 2 months after consulted with an ophthalmologist in the rural area. According to EUGOGO guidelines, TED with sight-threatening condition should be treated with glucocorticoid IV 500-1000 mg for 3 days consecutively. Although the patient was already given steroid injection for the initial treatment, the dosage was inadequate. After the inflammation process was reduced, the patient was reluctant to have an orbital decompression that was suggested. Hence, TED progressed continuously besides sight-threatening complications arising. He indeed underwent fat decompression and tarsorrhaphy as eyelid surgery to prevent corneal exposure. In follow-up, both visual acuity and corneal improvement were finally achieved. In the management of TED, collaboration between ophthalmologist and internist, who may be specialized in endocrinology, is imperative. They should be able to manage TED promptly and correctly, hence sight-threatening and other complications can be prevented and satisfactory results are achieved. Fat decompression should be considered as a good help to improve visual acuity nevertheless orbital decompression cannot be done.

Kata kunci

Jaringan kolaborasi para penulis

34 penulis · 257 tautan kepenulisan bersama · 2 lintas organisasi

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • University of Indonesia
  • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Imam SubektiAfiliasi tidak diketahui3
Dante Saksono HarbuwonoAfiliasi tidak diketahui2
Tri Juli Edi TariganUniversity of Indonesia2
Indrati SuroyoAfiliasi tidak diketahui2
Syntia NusantiRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo2
Esthika DewiastyAfiliasi tidak diketahui1
Dyah PurnamasariAfiliasi tidak diketahui1
Pradana SoewondoAfiliasi tidak diketahui1
Suharko SoebardiAfiliasi tidak diketahui1
Wismandari WisnuAfiliasi tidak diketahui1
Budiman DarmowidjojoAfiliasi tidak diketahui1
Dicky Levenus TahaparyAfiliasi tidak diketahui1
Farid KurniawanAfiliasi tidak diketahui1
Alvita Dewi SiswoyoAfiliasi tidak diketahui1
Soehartati GondhowiardjoAfiliasi tidak diketahui1
Henry KodratAfiliasi tidak diketahui1
M SidikAfiliasi tidak diketahui1
Salmarezka DewiputriAfiliasi tidak diketahui1
Gusti G SuardanaAfiliasi tidak diketahui1
Vally WulaniAfiliasi tidak diketahui1
Em YunirUniversity of Indonesia1
Renindra A AmanAfiliasi tidak diketahui1
Fransiskus Xaverius RinaldiAfiliasi tidak diketahui1
Ramzi RamziAfiliasi tidak diketahui1
Leonard HidayatAfiliasi tidak diketahui1
Ande FachniadinAfiliasi tidak diketahui1
Affan Priyambodo PermanaAfiliasi tidak diketahui1
Liem Arinuryanto LiosAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Sight-Threatening Condition in Severe Thyroid Eye Disease: How We Should Manage</dc:title>
	<dc:creator>Irawati, Yunia</dc:creator>
	<dc:creator>Juhrie, Dewi Megasari</dc:creator>
	<dc:creator>Paramita, Carennia</dc:creator>
	<dc:creator>Siswoyo, Darmayanti</dc:creator>
	<dc:creator>Suharko, Hernawita</dc:creator>
	<dc:creator>Pramono, Laurentius Aswin</dc:creator>
	<dc:subject xml:lang="en-US">grave’s disease</dc:subject>
	<dc:subject xml:lang="en-US">thyroid eye disease</dc:subject>
	<dc:subject xml:lang="en-US">dysthyroid optic neuropathy</dc:subject>
	<dc:subject xml:lang="en-US">orbital decompression</dc:subject>
	<dc:subject xml:lang="en-US">fat decompression</dc:subject>
	<dc:description xml:lang="en-US">Thyroid eye disease (TED) is an autoimmune disorder that is associated with thyroid gland dysfunction which causes muscle and orbital fat enlargement. This case report is aimed to present a case of sight-threatening TED and how we should manage this condition. We present a case of patient with chief complaint of vision loss and prominent eyes for 5 months prior to the visit to our eye hospital. Patient had sought advice from an ophthalmologist and internist. TED was eventually diagnosed 2 months after consulted with an ophthalmologist in the rural area. According to EUGOGO guidelines, TED with sight-threatening condition should be treated with glucocorticoid IV 500-1000 mg for 3 days consecutively. Although the patient was already given steroid injection for the initial treatment, the dosage was inadequate. After the inflammation process was reduced, the patient was reluctant to have an orbital decompression that was suggested. Hence, TED progressed continuously besides sight-threatening complications arising. He indeed underwent fat decompression and tarsorrhaphy as eyelid surgery to prevent corneal exposure. In follow-up, both visual acuity and corneal improvement were finally achieved. In the management of TED, collaboration between ophthalmologist and internist, who may be specialized in endocrinology, is imperative. They should be able to manage TED promptly and correctly, hence sight-threatening and other complications can be prevented and satisfactory results are achieved. Fat decompression should be considered as a good help to improve visual acuity nevertheless orbital decompression cannot be done.</dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2022-04-08</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/1214</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 54 No. 1 (2022): Acta Medica Indonesiana; 124</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/1214/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2022 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>